Iovance Biotherapeutics Inc
NASDAQ:IOVA
Income Statement
Earnings Waterfall
Iovance Biotherapeutics Inc
Revenue
|
1.9m
USD
|
Cost of Revenue
|
-18m
USD
|
Gross Profit
|
-16.1m
USD
|
Operating Expenses
|
-451.3m
USD
|
Operating Income
|
-467.4m
USD
|
Other Expenses
|
17.8m
USD
|
Net Income
|
-449.6m
USD
|
Income Statement
Iovance Biotherapeutics Inc
Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+196%
|
1
+67%
|
2
+60%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(6)
|
(11)
|
(18)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(2)
N/A
|
(6)
-214%
|
(10)
-68%
|
(16)
-68%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(24)
|
(25)
|
(19)
|
(12)
|
(15)
|
(19)
|
(24)
|
(28)
|
(30)
|
(35)
|
(46)
|
(54)
|
(68)
|
(79)
|
(83)
|
(93)
|
(99)
|
(107)
|
(119)
|
(128)
|
(141)
|
(160)
|
(177)
|
(207)
|
(238)
|
(251)
|
(259)
|
(262)
|
(267)
|
(285)
|
(312)
|
(343)
|
(359)
|
(377)
|
(391)
|
(399)
|
(418)
|
(427)
|
(441)
|
(451)
|
(451)
|
|
Selling, General & Administrative |
(4)
|
(4)
|
(3)
|
(4)
|
(4)
|
(7)
|
(9)
|
(12)
|
(14)
|
(18)
|
(26)
|
(26)
|
(27)
|
(24)
|
(18)
|
(21)
|
(24)
|
(27)
|
(29)
|
(28)
|
(31)
|
(35)
|
(38)
|
(41)
|
(46)
|
(49)
|
(55)
|
(60)
|
(66)
|
(71)
|
(76)
|
(84)
|
(87)
|
(94)
|
(101)
|
(104)
|
(109)
|
(104)
|
(103)
|
(107)
|
(110)
|
|
Research & Development |
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(8)
|
(13)
|
(15)
|
(17)
|
(17)
|
(20)
|
(28)
|
(40)
|
(56)
|
(65)
|
(72)
|
(75)
|
(80)
|
(90)
|
(100)
|
(111)
|
(126)
|
(139)
|
(166)
|
(192)
|
(202)
|
(204)
|
(202)
|
(201)
|
(214)
|
(236)
|
(259)
|
(271)
|
(283)
|
(290)
|
(295)
|
(309)
|
(322)
|
(337)
|
(344)
|
(341)
|
|
Other Operating Expenses |
(19)
|
(20)
|
(14)
|
(6)
|
(6)
|
(4)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(24)
N/A
|
(25)
-4%
|
(19)
+26%
|
(12)
+36%
|
(15)
-25%
|
(19)
-29%
|
(24)
-25%
|
(28)
-15%
|
(30)
-6%
|
(35)
-18%
|
(46)
-33%
|
(54)
-16%
|
(68)
-26%
|
(79)
-18%
|
(83)
-4%
|
(93)
-12%
|
(99)
-6%
|
(107)
-8%
|
(119)
-12%
|
(128)
-7%
|
(141)
-10%
|
(160)
-13%
|
(177)
-10%
|
(207)
-17%
|
(238)
-15%
|
(251)
-6%
|
(259)
-3%
|
(262)
-1%
|
(267)
-2%
|
(285)
-7%
|
(312)
-10%
|
(343)
-10%
|
(359)
-5%
|
(377)
-5%
|
(391)
-4%
|
(399)
-2%
|
(418)
-5%
|
(428)
-2%
|
(446)
-4%
|
(461)
-3%
|
(467)
-1%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
5
|
7
|
9
|
10
|
9
|
7
|
5
|
4
|
2
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
3
|
6
|
9
|
12
|
13
|
13
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(27)
N/A
|
(25)
+5%
|
(19)
+26%
|
(12)
+36%
|
(15)
-25%
|
(19)
-28%
|
(24)
-25%
|
(28)
-14%
|
(29)
-6%
|
(34)
-18%
|
(46)
-32%
|
(53)
-16%
|
(67)
-26%
|
(79)
-18%
|
(82)
-4%
|
(92)
-12%
|
(98)
-6%
|
(105)
-7%
|
(117)
-11%
|
(124)
-6%
|
(134)
-8%
|
(151)
-13%
|
(167)
-10%
|
(198)
-19%
|
(230)
-17%
|
(246)
-7%
|
(255)
-4%
|
(260)
-2%
|
(265)
-2%
|
(284)
-7%
|
(311)
-10%
|
(342)
-10%
|
(358)
-5%
|
(376)
-5%
|
(390)
-4%
|
(396)
-2%
|
(412)
-4%
|
(419)
-2%
|
(435)
-4%
|
(448)
-3%
|
(455)
-2%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
5
|
|
Income from Continuing Operations |
(27)
|
(25)
|
(19)
|
(12)
|
(15)
|
(19)
|
(24)
|
(28)
|
(29)
|
(34)
|
(46)
|
(53)
|
(67)
|
(79)
|
(82)
|
(92)
|
(98)
|
(105)
|
(117)
|
(124)
|
(134)
|
(151)
|
(167)
|
(198)
|
(230)
|
(246)
|
(255)
|
(260)
|
(265)
|
(284)
|
(311)
|
(342)
|
(358)
|
(376)
|
(390)
|
(396)
|
(412)
|
(419)
|
(433)
|
(444)
|
(450)
|
|
Net Income (Common) |
(35)
N/A
|
(34)
+4%
|
(27)
+20%
|
(12)
+56%
|
(15)
-25%
|
(19)
-28%
|
(24)
-25%
|
(28)
-14%
|
(29)
-6%
|
(34)
-18%
|
(95)
-176%
|
(102)
-8%
|
(116)
-13%
|
(128)
-10%
|
(82)
+36%
|
(92)
-12%
|
(98)
-6%
|
(105)
-7%
|
(117)
-11%
|
(124)
-6%
|
(134)
-8%
|
(151)
-13%
|
(167)
-10%
|
(198)
-19%
|
(230)
-17%
|
(246)
-7%
|
(255)
-4%
|
(260)
-2%
|
(265)
-2%
|
(284)
-7%
|
(311)
-10%
|
(342)
-10%
|
(358)
-5%
|
(376)
-5%
|
(390)
-4%
|
(396)
-2%
|
(412)
-4%
|
(419)
-2%
|
(433)
-3%
|
(444)
-3%
|
(450)
-1%
|
|
EPS (Diluted) |
-1.68
N/A
|
-1.11
+34%
|
-1.01
+9%
|
-0.48
+52%
|
-0.4
+17%
|
-0.36
+10%
|
-0.51
-42%
|
-0.62
-22%
|
-0.6
+3%
|
-0.67
-12%
|
-1.6
-139%
|
-1.85
-16%
|
-1.86
-1%
|
-2.04
-10%
|
-1.3
+36%
|
-1.41
-8%
|
-1.16
+18%
|
-1.16
N/A
|
-1.22
-5%
|
-1.27
-4%
|
-1.08
+15%
|
-1.22
-13%
|
-1.35
-11%
|
-1.59
-18%
|
-1.83
-15%
|
-1.84
-1%
|
-1.73
+6%
|
-1.88
-9%
|
-1.8
+4%
|
-1.84
-2%
|
-2
-9%
|
-2.23
-12%
|
-2.29
-3%
|
-2.39
-4%
|
-2.47
-3%
|
-2.49
-1%
|
-1.92
+23%
|
-1.86
+3%
|
-1.76
+5%
|
-1.89
-7%
|
-1.68
+11%
|